A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
Clinical trial NCT05278182 · UNKNOWN
Trial details
- NCT number
- NCT05278182
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2025-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.